$TDOCNeutralLow

Nueno Carlos sold $47K of TDOC

Nueno Carlos (President, International) sold 6,196 shares of Teladoc Health, Inc. (TDOC) at $7.63 on 2026-06-02.

7/10
6/10
Low
Neutral
Filed June 3, covering a sale executed June 2.
Neutral-to-slightly negative optics from insider selling; no new fundamentals provided.

This is an insider selling disclosure; it may modestly affect sentiment but is not a fundamental catalyst by itself.

Teladoc Health officer Nueno Carlos sold 6,196 shares in an open-market transaction worth about $47.3K, per SEC Form 4.

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment/flow optics.

Background

SEC Form 4 reports insider transactions (officers/directors/10% owners) in the issuer’s own stock.

Why it matters

The key tradable element is the disclosed insider sale details (date, shares, price, and post-transaction holdings), which can influence short-term sentiment.

Market relevance

A single officer’s small open-market sale is primarily a sentiment/flow datapoint rather than a fundamental driver.

Market effects

Minimal; insider selling in one healthcare/telehealth name is not a sector-wide signal on its own.

None indicated.

None indicated.

Alternative perspectives

Insider sales can be routine liquidity/portfolio rebalancing and may not reflect negative expectations.

The sale is not under a 10b5-1 plan, but the disclosed size ($47K) is small relative to typical market capitalization, limiting interpretability.

Key entities

  • Nueno Carlos

    President, International at Teladoc Health; reported an open-market sale of TDOC shares.

  • Teladoc Health, Inc.

    TDOC; insider selling disclosure filed via SEC EDGAR Form 4.

Related articles

$TDOCMedAI 8/10

TDOC Stock Pops as Teladoc Teams Up With Walmart

Barchart reports that Teladoc Health’s consensus rating remains “Moderate Buy,” with a mean price target of $7.24, suggesting limited additional upside versus current levels. The stock rose after Teladoc announced a partnership with Walmart, according to the article.

$TDOCMedAI 8/10

Could This Beaten‑Down Stock Be a Millionaire‑Maker Over the Next Decade?

Teladoc Health’s stock has fallen more than 90% over five years, and the company remains unprofitable. In Q1, revenue fell 2% year over year to $613.8 million and net loss per share improved to $0.36, but a 2025 goodwill impairment charge hurt results. BetterHelp revenue and paying users declined 9% y/y, while international revenue rose 17% to $122.3 million.

$LZMed

Spotting Winners: LegalZoom (NASDAQ:LZ) And Online Marketplace Stocks In Q1

The article reviews Q1 results for online marketplace stocks. Shutterstock (SSTK) reported revenue of $199.2M, down 17.9% YoY and 10.2% below analyst expectations, and its shares fell 7.9% to $16.24. EverQuote (EVER) posted $190.9M revenue, up 14.5% YoY and 5.7% above estimates, with shares up 29.2% to $18.88. Teladoc (TDOC) revenue was $613.8M, down 2.5% YoY but 0.5% above estimates; shares rose 9.8% to $6.54.